Barclays PLC Amarin Corp Plcuk Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Barclays PLC holds 11,489 shares of AMRN stock, worth $6,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,489

Previous 11,489 -0.0%

Holding current value

$6,089

Previous $7,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$0.57 - $0.8 $1,133 - $1,591	1,989 Added 20.94%	11,489 $7,000
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $101 - $332	-90 Reduced 0.94%	9,500 $14,000
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $48,501 - $63,477	-17,018 Reduced 63.96%	9,590 $31,000
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $117,676 - $188,137	-36,320 Reduced 57.72%	26,608 $89,000
Q3 2021 Nov 09, 2021	BUY	$3.94 - $5.84 $5,740 - $8,508	1,457 Added 2.37%	62,928 $321,000
Q2 2021 Aug 13, 2021	SELL	$4.26 - $6.5 $6,372 - $9,724	-1,496 Reduced 2.38%	61,471 $269,000
Q1 2021 May 13, 2021	BUY	$5.03 - $8.8 $116,962 - $204,626	23,253 Added 58.55%	62,967 $391,000
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $36,400 - $77,600	-10,000 Reduced 20.12%	39,714 $167,000
Q2 2020 Aug 12, 2020	SELL	$4.78 - $8.26 $4.03 Million - $6.97 Million	-844,004 Reduced 94.44%	49,714 $344,000
Q1 2020 May 13, 2020	BUY	$4.0 - $21.53 $10,584 - $56,968	2,646 Added 0.3%	893,718 $3.58 Million
Q4 2019 Feb 10, 2020	BUY	$13.94 - $24.12 $2.6 Million - $4.51 Million	186,827 Added 26.53%	891,072 $19.1 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $1.58 Million - $2.63 Million	113,603 Added 19.23%	704,245 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $4.12 Million - $5.2 Million	253,517 Added 75.2%	590,642 $11.5 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $8.53 Million - $15.1 Million	-676,699 Reduced 66.75%	337,125 $7 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $8.37 Million - $15.5 Million	674,349 Added 198.64%	1,013,824 $13.8 Million
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $730,712 - $4.85 Million	-298,250 Reduced 46.77%	339,475 $5.52 Million
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $287,314 - $373,080	107,207 Added 20.21%	637,725 $1.97 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $760,760 - $1.13 Million	254,435 Added 92.16%	530,518 $1.6 Million
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $321,872 - $430,214	105,187 Added 61.55%	276,083 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $517,814 - $635,733	170,896	170,896 $598,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account